Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 1
2016 1
2021 1
2022 1
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
Ayhan M, Laçin Ş, Özyükseler DT, Sürmeli H, Doğan A, Turan M, Odabas H, Turan N, Yıldırım ME. Ayhan M, et al. Among authors: dogan a. J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762. Epub 2021 May 7. J Oncol Pharm Pract. 2021. PMID: 33961521 Free PMC article.
A case of recurrent renal aluminum hydroxide stone.
Cakıroglu B, Dogan AN, Tas T, Gozukucuk R, Uyanik BS. Cakıroglu B, et al. Among authors: dogan an. Case Rep Urol. 2014;2014:212314. doi: 10.1155/2014/212314. Epub 2014 Jun 9. Case Rep Urol. 2014. PMID: 25013740 Free PMC article.
An unusual cause of hematuria; primary epiploic appendagitis.
Cakiroglu B, Sinanoglu O, Abci İ, Tas T, Dogan AN, Aksoy SH, Bilsel Y. Cakiroglu B, et al. Among authors: dogan an. Int J Surg Case Rep. 2014;5(12):902-5. doi: 10.1016/j.ijscr.2014.09.012. Epub 2014 Oct 28. Int J Surg Case Rep. 2014. PMID: 25460432 Free PMC article.
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Yıldırım HÇ, Mutlu E, Chalabiyev E, Özen M, Keskinkılıç M, Ön S, Çelebi A, Dursun B, Acar Ö, Kahraman S, Aykan MB, Kaman Ö, Doğan A, Erdoğan AP, Melisa Celayir Ö, Günenç D, Güven DC, Vedat Bayoğlu İ, Yavuzşen T, Hacıbekiroğlu İ, İnanç M, Kılıçkap S, Yalçın Ş, Aksoy S. Yıldırım HÇ, et al. Among authors: dogan a. Breast. 2022 Dec;66:85-88. doi: 10.1016/j.breast.2022.09.009. Epub 2022 Sep 30. Breast. 2022. PMID: 36208540 Free PMC article.
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N, Sarı M, Kahvecioglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arıkan R, Isık S, Balvan O, Geredelı C, Uygun K, Hacibekiroglu I, Kostek O, Bayoglu IV. Majidova N, et al. Among authors: dogan a. Oncol Res Treat. 2024 Apr 2:1-7. doi: 10.1159/000537988. Online ahead of print. Oncol Res Treat. 2024. PMID: 38565096
Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data.
Sütcüoğlu O, Doğan A, Yilmaz F, Şahin AB, Şahin TK, Esen SA, Erol C, Üner A, Özet A, Turan N, Eraslan E, Deligönül A, Odabaş H, Günel N, Uçar G, Dede DŞ, Dizdar Ö, Çubukçu E, Öksüzoğlu ÖB, Emre Yildirim M, Yazici O, Özdemir N. Sütcüoğlu O, et al. Among authors: dogan a. Pancreas. 2023 Apr 1;52(4):e235-e240. doi: 10.1097/MPA.0000000000002238. Epub 2023 Oct 25. Pancreas. 2023. PMID: 37816170
14 results